Phase I, Randomized, Placebo Controlled Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release In Healthy Male Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2010
At a glance
- Drugs PF 4455242; Spiradoline
- Indications Bipolar depression
- Focus Pharmacodynamics
- Sponsors Pfizer
- 08 Jan 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 08 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.